Met Life Investment Management, LLC Care Dx, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 31,034 shares of CDNA stock, worth $561,405. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,034
Previous 28,900 7.38%
Holding current value
$561,405
Previous $902,000 26.39%
% of portfolio
0.0%
Previous 0.01%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$20.4 - $32.2 $43,533 - $68,714
2,134 Added 7.38%
31,034 $664,000
Q3 2024

Nov 13, 2024
SELL
$14.41 - $33.99 $20,808 - $49,081
-1,444 Reduced 4.76%
28,900 $902,000
Q2 2024

Aug 13, 2024
BUY
$7.56 - $16.15 $20,858 - $44,557
2,759 Added 10.0%
30,344 $471,000
Q1 2024

May 14, 2024
BUY
$7.96 - $12.37 $219,576 - $341,226
27,585 New
27,585 $292,000
Q2 2023

Apr 29, 2024
BUY
$7.61 - $9.46 $209,921 - $260,954
27,585 New
27,585 $234,000
Q1 2023

May 09, 2024
BUY
$8.83 - $17.61 $243,575 - $485,771
27,585 New
27,585 $252 Million
Q1 2022

May 10, 2024
BUY
$28.19 - $46.6 $777,621 - $1.29 Million
27,585 New
27,585 $1.02 Million
Q1 2022

Mar 22, 2023
BUY
$28.19 - $46.6 $280,152 - $463,110
9,938 Added 56.32%
27,585 $1.02 Million
Q1 2022

May 12, 2022
BUY
$28.19 - $46.6 $280,152 - $463,110
9,938 Added 56.32%
27,585 $1.02 Million
Q4 2021

Jun 21, 2023
SELL
$41.2 - $73.6 $409,445 - $731,436
-9,938 Reduced 36.03%
17,647 $802,000
Q3 2021

Jun 21, 2023
SELL
$59.15 - $91.99 $587,832 - $914,196
-9,938 Reduced 36.03%
17,647 $1.12 Million
Q2 2021

May 17, 2024
SELL
$63.02 - $95.11 $79,027 - $119,267
-1,254 Reduced 6.63%
17,647 $1.62 Million
Q2 2021

Jun 21, 2023
SELL
$63.02 - $95.11 $626,292 - $945,203
-9,938 Reduced 36.03%
17,647 $1.62 Million
Q2 2021

Mar 22, 2023
SELL
$63.02 - $95.11 $79,027 - $119,267
-1,254 Reduced 6.63%
17,647 $1.62 Million
Q2 2021

Aug 16, 2021
SELL
$63.02 - $95.11 $79,027 - $119,267
-1,254 Reduced 6.63%
17,647 $1.62 Million
Q1 2021

May 17, 2024
SELL
$57.62 - $95.6 $500,372 - $830,190
-8,684 Reduced 31.48%
18,901 $1.29 Million
Q1 2021

Jun 26, 2023
SELL
$57.62 - $95.6 $500,372 - $830,190
-8,684 Reduced 31.48%
18,901 $1.29 Billion
Q4 2020

May 24, 2024
SELL
$41.43 - $77.09 $64,920 - $120,800
-1,567 Reduced 7.66%
18,901 $1.37 Million
Q4 2020

Jun 22, 2023
SELL
$41.43 - $77.09 $359,778 - $669,449
-8,684 Reduced 31.48%
18,901 $1.37 Million
Q4 2020

Mar 22, 2023
SELL
$41.43 - $77.09 $64,920 - $120,800
-1,567 Reduced 7.66%
18,901 $1.37 Million
Q4 2020

Feb 16, 2021
SELL
$41.43 - $77.09 $64,920 - $120,800
-1,567 Reduced 7.66%
18,901 $1.37 Million
Q3 2020

May 24, 2024
BUY
$30.88 - $37.94 $51,631 - $63,435
1,672 Added 8.9%
20,468 $777 Million
Q3 2020

Jun 26, 2023
SELL
$30.88 - $37.94 $219,772 - $270,018
-7,117 Reduced 25.8%
20,468 $776,000
Q3 2020

Mar 22, 2023
BUY
$30.88 - $37.94 $51,631 - $63,435
1,672 Added 8.9%
20,468 $776,000
Q3 2020

Nov 13, 2020
BUY
$30.88 - $37.94 $51,631 - $63,435
1,672 Added 8.9%
20,468 $777,000
Q2 2020

May 24, 2024
SELL
$18.95 - $35.43 $166,551 - $311,394
-8,789 Reduced 31.86%
18,796 $666 Million
Q2 2020

Jun 26, 2023
SELL
$18.95 - $35.43 $166,551 - $311,394
-8,789 Reduced 31.86%
18,796 $665,000
Q1 2020

Jul 12, 2023
SELL
$13.94 - $28.25 $122,518 - $248,289
-8,789 Reduced 31.86%
18,796 $410,000
Q4 2019

Jul 12, 2023
SELL
$19.24 - $28.41 $169,100 - $249,695
-8,789 Reduced 31.86%
18,796 $405,000
Q3 2019

Jul 12, 2023
SELL
$20.03 - $40.08 $176,043 - $352,263
-8,789 Reduced 31.86%
18,796 $424,000
Q3 2019

Mar 22, 2023
BUY
$20.03 - $40.08 $54,401 - $108,857
2,716 Added 16.89%
18,796 $424,000
Q3 2019

Nov 14, 2019
BUY
$20.03 - $40.08 $54,401 - $108,857
2,716 Added 16.89%
18,796 $425,000
Q2 2019

Jul 12, 2023
SELL
$25.78 - $39.77 $226,580 - $349,538
-8,789 Reduced 31.86%
18,796 $676,000
Q1 2019

Jul 13, 2023
SELL
$22.09 - $39.21 $254,145 - $451,111
-11,505 Reduced 41.71%
16,080 $506,000
Q4 2018

Jul 13, 2023
SELL
$19.89 - $30.02 $228,834 - $345,380
-11,505 Reduced 41.71%
16,080 $404,000
Q4 2018

Mar 22, 2023
SELL
$19.89 - $30.02 $176,404 - $266,247
-8,869 Reduced 35.55%
16,080 $404,000
Q4 2018

Feb 14, 2019
SELL
$19.89 - $30.02 $176,404 - $266,247
-8,869 Reduced 35.55%
16,080 $404,000
Q3 2018

Jul 13, 2023
SELL
$12.1 - $28.85 $139,210 - $331,919
-11,505 Reduced 41.71%
16,080 $463,000
Q3 2018

Mar 22, 2023
SELL
$12.1 - $28.85 $31,895 - $76,048
-2,636 Reduced 9.56%
24,949 $719,000
Q3 2018

Nov 14, 2018
BUY
$12.1 - $28.85 $107,314 - $255,870
8,869 Added 55.16%
24,949 $720,000
Q2 2018

Aug 15, 2018
BUY
$7.93 - $15.79 $127,514 - $253,903
16,080 New
16,080 $197,000

Others Institutions Holding CDNA

# of Institutions
216
Shares Held
53.3M
Call Options Held
53.5K
Put Options Held
23.9K
View Full List

About CareDx, Inc.

CDNA Quotes by TradingView
  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $967M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email